Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3351–3400 of 18625
Effective as of November 5, 2024, due to the illness of the Chief Executive Officer, Charles Wert, Oanh Truong was appointed as interim Chief Executive Officer of Coliseum Acquisition Corp.
due to the illness of the Chief Executive Officer, Charles Wert
On November 8, 2024, iSpecimen Inc. (the “Company”) and Tracy Curley mutually agreed to end Ms. Curley’s employment as Chief Executive Officer, Chief Financial Officer and Treasurer of the Company.
On November 7, 2024, Joseph E. Sutaris notified Community Financial System, Inc. (the “Company”) of his intention to retire, effective in or around the third quarter of 2025, from his position as the Executive Vice President (“EVP”) and Chief Financial Officer of the Company
Ms. Cathy W. Liles, age 59, has been appointed to the position of Senior Vice President and Chief Financial Officer of the Company and Executive Vice President and Chief Financial Officer of The Old Point National Bank of Phoebus (the “Bank”) effective as of November 6, 2024.
the resignation of Mr. William H. Craig as Chief Financial Officer and Treasurer of the Company
the Company’s board of directors (“Board”) appointed George A. Makris, Jr. (age 68) as chairman and chief executive officer of the Company, effective January 1, 2025
Robert A. Fehlman (age 60), the chief executive officer of Simmons First National Corporation (“Company”), provided the Company notice of his decision to resign from his position, effective as of the end of the day December 31, 2024, to focus on personal interests and family medical issues.
Appointment of Officers Immediately upon consummation of the Transaction, the executive officers of the Company are: (i) Robbert Rietbroek, as Chief Executive Officer; (ii) David Hass, as Chief Financial Officer; (iii) Robert Austin, as Chief Operating Officer, (iv) Jason Ausher, as Chief Accounting Officer; (v) Marni Morgan Poe, as General Counsel & Corporate Secretary; and (vi) Hih Song Kim, as Chief Administrative Officer & Assistant Corporate Secretary.
Appointment of Officers Immediately upon consummation of the Transaction, the executive officers of the Company are: (i) Robbert Rietbroek, as Chief Executive Officer; (ii) David Hass, as Chief Financial Officer; (iii) Robert Austin, as Chief Operating Officer, (iv) Jason Ausher, as Chief Accounting Officer; (v) Marni Morgan Poe, as General Counsel & Corporate Secretary; and (vi) Hih Song Kim, as Chief Administrative Officer & Assistant Corporate Secretary.
On November 11, 2024, Altimmune, Inc. (the “Company”) issued a press release announcing the decision of the Company’s Board of Directors (the “Board”) to appoint Mr. Gregory Weaver as the Company’s Chief Financial Officer (“CFO”), effective November 11, 2024.
The board of directors of the Company has appointed Constance B. Moore to serve as the Company's Interim President and Chief Executive Officer effective November 11, 2024.
On November 11, 2024, Healthcare Realty Trust Incorporated (the "Company") and Todd J. Meredith determined that Mr. Meredith would depart from his position as President and Chief Executive Officer of the Company, effective November 11, 2024.
the Board approved the appointment of Scott R. Cutler as President and Chief Executive Officer, effective as of January 6, 2025
Jon Kessler, President & Chief Executive Officer of the Company and a member of the Board of Directors (the “Board”), will retire from his employment with the Company, effective January 6, 2025
Herman Cueto, who is departing from his role at the Company.
appointed Lawrence Lin as its Executive Vice President and Chief Financial Officer, effective as of Effective Time
Mr. Dellal will resign from his role as of the Effective Date.
On November 11, 2024 , the Board of Directors of Two Harbors Investment Corp. (the “Company”) approved the appointment of Travis Swenson as Chief Financial Officer of the Company, with an effective date of May 5, 2025
On November 6, 2024 (the “Effective Date”), the Company entered into an employment agreement with Mr. Waqas Nakhwa in connection with his appointment as Chief Executive Officer, President, Chief Financial Officer, Treasurer, Secretary, and as Chairman of the Company’s Board of Directors
Mr. Kevin Zaccardi resigned as the Interim-Chief Financial Officer of Starco Brands, Inc. (the “Company”), effective November 8, 2024, to pursue another opportunity.
On November 8, 2024, the Board unanimously approved the appointment of Mr. Sklar, the Company’s current Chief Executive Officer and President, and member of the Board, to the position of Interim-Chief Financial Officer and Treasurer, effective November 8, 2024.
the Company appointed Peter F. Longo as President and CEO of the Company.
On November 6, 2024, the Company announced the engagement of James Richardson as Chief Financial Officer of the Company, effective January 1, 2025.
On November 5, 2024, our board of directors appointed Annalisa Bloodworth, 46, as our next President and Chief Executive Officer.
On November 7, 2024, the Board approved the appointment of Douglas Francis, age 47, to serve as Chief Executive Officer of the Company, effective as of November 7, 2024.
On November 7, 2024, the Board approved the appointment of Ms. Echard as the Company’s permanent Chief Financial Officer.
his appointment as Executive Vice President and Chief Financial Officer is now effective November 8, 2024.
On the same day, the board of directors of the Company appointed Christopher Bradley, who concurrently serves as Chief Financial Officer and secretary of the Company, as a director, Chief Executive Officer and chairman of the Company.
elected Robert J. Francescon, the Company’s current Co-Chief Executive Officer and President, as sole Chief Executive Officer and President
William T. Presley has been hired as the successor President and Chief Executive Officer of the Company, and has been appointed by the Board as a director of the Company, each effective January 1, 2025
Dan Geffken tendered his resignation as interim Chief Financial Officer, principal financial officer and principal accounting officer of CalciMedica, Inc.
the Company’s board of directors (the “Board”) appointed Stephen Bardin as the Company’s Chief Financial Officer, as well as the Company’s principal financial officer and principal accounting officer effective as of the Effective Date.
Beverly Kay Matthews, Eric A. Benhamou, Elizabeth Burr, Richard D. Daniels, Alison Davis, Joel P. Friedman, Thomas King, Jeffrey N. Maggioncalda, Mary J. Miller, Kate D. Mitchell, Garen K. Staglin, Allen Parker, Steven G. Panagos, and the Company’s remaining officers, including Bill Kosturos, Chief Restructuring Officer, Nicholas Grossi, Interim Chief Financial Officer, and Jeff Liu, Assistant Chief Restructuring Officer, ceased to be directors and officers of the Company on the Effective Date.
Immediately upon consummation of the Transaction, the executive officers of the Company are: (i) Robbert Rietbroek, as Chief Executive Officer; (ii) David Hass, as Chief Financial Officer; (iii) Robert Austin, as Chief Operating Officer, (iv) Jason Ausher, as Chief Accounting Officer; (v) Marni Morgan Poe, as General Counsel & Corporate Secretary; and (vi) Hih Song Kim, as Chief Administrative Officer & Assistant Corporate Secretary.
Immediately upon consummation of the Transaction, the executive officers of the Company are: (i) Robbert Rietbroek, as Chief Executive Officer; (ii) David Hass, as Chief Financial Officer; (iii) Robert Austin, as Chief Operating Officer, (iv) Jason Ausher, as Chief Accounting Officer; (v) Marni Morgan Poe, as General Counsel & Corporate Secretary; and (vi) Hih Song Kim, as Chief Administrative Officer & Assistant Corporate Secretary.
Mr. Ruifeng (Steven) Guo, the Chief Financial Officer and a director of the board of the directors (the “Board”) of Fly-E Group, Inc. (the “Company”), tendered his resignation as Chief Financial Officer and director of the Company, effective November 6, 2024.
the Board appointed Ms. Shiwen Feng as the Company’s Chief Financial Officer and a director to fill the vacancies created by the resignation of Mr. Guo, effective November 7, 2024.
Effective November 6, 2024, Mr. Zhibiao Pan resigned as Co-Chief Executive Officer of China Green Agriculture Inc.
Mark A. Hernandez resigned as Chief Executive Officer of The Eastern Company (the "Company"), and from service on the Board of Directors of the Company (the "Board") and all other officer, director, trustee, fiduciary and other positions with the Company and its subsidiaries and affiliates, effective as of the Separation Date.
On November 4, 2024, the Company appointed Ryan Schroeder to serve as the Company’s Chief Executive Officer, effective November 6, 2024.
On November 7, 2024, Francesca Weissman entered into a letter agreement with the Company that provides for her compensation as Chief Financial Officer. Effective as of December 1, 2024, Ms. Weissman will receive an initial annual base salary of $550,000
On November 4, 2024, Dominique Bourgault, our Chief Financial Officer, informed us of his decision to resign from that position, effective December 2, 2024.
On November 6, 2024, the Board of Directors of Titan Pharmaceuticals, Inc. (the “Company”) appointed Brynner Chiam, a director of the Company, as acting principal executive officer and acting principal financial officer of the Company.
Effective November 11, 2024, the Registrant appointed Joseph Cleghorn, age 64, as a director of the Company, Chairman of the Board of Directors, Chief Executive Officer, and interim Chief Financial Officer.
Additionally, on November 6, 2024, the Company appointed Simon D. Campion, the Company’s President and Chief Executive Officer and a member of the Company’s Board of Directors, to the additional role of interim principal financial officer
the date upon which Glenn G. Coleman will resign as the Company’s Executive Vice President, Chief Financial Officer, principal financial officer, and interim principal accounting officer, as has been previously disclosed.
Joseph F. Fadool, currently the Company’s Executive Vice President of BorgWarner Inc. and Chief Operating Officer, has been appointed to succeed him as President and Chief Executive Officer.
Frederic B. Lissalde, the President and Chief Executive Officer of the Company, will retire
Gary A. Shiffman, Chairman of the Board and Chief Executive Officer of Sun Communities, Inc. (the “Company”), informed the Company’s Board of Directors of his intent to retire as Chief Executive Officer
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.